Vitamin D and the endothelium: Basic, translational and clinical research updates

IJC Metabolic and Endocrine

Volumn 4, Issue , 2014, Pages 4-17

  Dalan, Rinkoo ^a,b,c   Liew, Huiling ^a   Tan, Wai Kit Alvin ^a   Chew, Daniel E K ^a   Leow, Melvin Khee Shing ^a,b,c,d,e  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d AGENCY FOR SCIENCE   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cardiovascular; Endothelium; Surrogate endpoints; Survival outcomes; Vitamin D

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL; NITRIC OXIDE SYNTHASE; PLACEBO; REACTIVE OXYGEN METABOLITE; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN D;

CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; ENDOTHELIUM; ENDOTHELIUM INJURY; GENE EXPRESSION; HUMAN; NONHUMAN; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84908030207     PISSN: 22147624     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcme.2014.06.003     Document Type: Review

References (132)

1. Global status report on non communicable diseases 2010 2011, World Health Organisation, Geneva.
2. Cohn J.N., Quyyumi A.A., Hollenberg N.K., Jamerson K.A. Surrogate markers for cardiovascular disease: functional markers. Circulation 2004, 109(S1):IV36-IV41.
3. Holick M.F. Vitamin D: a millennium perspective. J Cell Biochem 2003, 88:296-307.
4. Holick M.F. Vitamin D, deficiency. N Engl J Med 2007, 357:266-281.
5. Daroux M., Shenouda M., Bacri J.L., Lemaitre V., Vanhille P., Bataille P. Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study. J Nephrol 2013, 26:152-157.
6. Logan V.F., Gray A.R., Peddie M.C., Harper M.J., Houghton L.A. Long term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months. Br J Nutr 2013, 109:1082-1088.
7. Tripkovic L., Lambert H., Hart K., Smith C.P., Bucca G., Penson S., et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analyses. Am J Clin Nutr 2012, 95:1357-1364.
8. Houghton L.A., Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006, 84:694-697.
9. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003, 77:204-210.
10. Lee J.H., O'Keefe J.H., Bell J., Hensrud D.D., Holick M.F. Vitamin D deficiency: an important, common and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008, 52:1949-1956.
11. Vieth R. Critique of the consideration for establishing the tolerable upper intake level of vitamin D: critical need for revision upwards. J Nutr 2006, 136:1117-1122.
12. Waterhouse M., Tran B., Armstrong B.K., Baxter C., Ebeling P.R., English D.R., et al. Environmental, personal and genetic determinants of response to vitamin D supplementation in older adults. J Clin Endocrinol Metab Apr 2 2014, jc20134101.
13. Didriksen A., Grimnes G., Hutchinson M.S., Kjærgaard M., J.Svartberg J., Joakimsen R.M., et al. The serum 25-hydroxyvitamin D response to vitamin D supplementation is related to genetic factors, BMI and baseline levels. Eur J Endocrinol 2013, 169:559-567.
14. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-716.
15. Endocrine Society Practice guidelines Evaluation, Treatment and Prevention of Vitamin D deficiency. J Clin Endocrinol Metab 2011, 96:1911-1930.
16. Holick M.F., MacLaughlin J.A., Dobbelt S.H. Regulation of cutaneous pre-vitamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science 1981, 211:590-593.
17. Holick M.F. Vitamin D, deficiency: what a pain it is. Mayo Clin Proc 2003, 78:1457-1459.
18. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008, 88:5825-5865.
19. Holick M.F., Garabedian M. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. Primer on the metabolic bone diseases and disorders of mineral metabolism 2006, 129-137. American Society for Bone and Mineral Research, Washington, DC. 6th ed. M.J. Favus (Ed.).
20. Norman A.W. From Vitamin D to hormone D; Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008, 88:491S-499S.
21. Szpirer J., Szpirer C., Riviere M., Levan G., Marynen P., Cassiman J.J., Wiese R., DeLuca H.F. The Sp1 transcription factor gene (SP1) and the 1,25-dihydroxyvitamin D3 receptor gene (VDR) are colocalized on human chromosome arm 12q and rat chromosome 7. Genomics 1991, 11:168-173.
22. Witfield G.R., Hsieh J.C., Juritka P.W., Selznik S.F., Haussler C.A., Macdonald P.N., Haussler M.K. Genomic actions of 1,25-dihydroxyvitamin D3. J Nutr 1995, 125:1690S-1694S.
23. Bouillon R., Okamura W.H., Norman A.W. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995, 16:200-257.
24. Carlberg C. Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 2003, 164:29-42.
25. Meyer M.B., Goetsch P.D., Pike J.W. Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone. J Steroid Biochem Mol Biol 2010, 121:136-141.
26. Haussler M.R., Haussler C.A., Whitfield G.K., Hsieh J.C., Thompson P.D., Barthel T.K., et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. J Steroid Biochem Mol Biol 2010, 121:88-97.
27. Plum L.A., DeLuca H.F. Vitamin D disease and therapeutic opportunities. Nat Rev Drug Discov 2010, 9:941-955.
28. Margueron R., Reinberg D. Chromatin structure and the inheritance of epigenetic information. Nat Rev Genet 2010, 11:285-296.
29. Ramagopalan S.V., Heger A., Berlanga A.J., Maugeri N.J., Lincoln M.R., Burrell A., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010, 20:1352-1360.
30. Zitman-Gal T., Green J., Pasmanik-Chor M., Golan E., Bernheim J., Benchetrit S. Vitamin D manipulates niR-181c, miR-20b and mir-15a in human umbilical vein endothelial cells exposed to a diabetic-like environment. Cardiovasc Diabetol 2014, 13:8.
31. Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.F., Wythe J.D., et al. mir-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008, 15:272-284.
32. Zitman-Gal T., Golan E., Green J., Bernheim J., Benchetrit S. Vitamin D receptor activation in a diabetic-like environment potential role in the activity of the endothelial pro-inflammatory and thioredoxin pathways. J Steroid Biochem Mol Biol 2012, 132:1-7.
33. Nakagami H., Kaneda Y., Ogihara T., Morishita R. Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis. Curr Diabetes Rev 2005, 1:59-63.
34. Jackson S.P. Arterial thrombus-Insidious, unpredictable and deadly. Nat Med 2011, 17:1423-1436.
35. Stamler J.S., Lamas S., Fang F.C. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 2001, 106:675-683.
36. Ghosh S., Karin M. Missing pieces in the NF-kB Puzzle. Cell 2002, 109:S81-S96.
37. Moncada S., Erasalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat Rev Mol Cell Biol 2002, 3:214-220.
38. Gimbrone M.A. Vascular endothelium, hemodynamic forces, and atherogenesis. Am J Pathol 1999, 155:1-5.
39. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
40. 2, a necessary evil for cell signaling. Science 2006, 312:1882-1883.
41. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., Deanfield J.E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994, 24:1468-1474.
42. Deanfield J.E., Halcox J.P., Rabelink T.N. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2012, 115:1285-1295.
43. Woywodt A., Bahlmann F.H., De Groot K., Haller H., Haubitz M. Circulating endothelial cells: life, death, detachment and repair of endothelial cell layer. Nephrol Dial Transplant 2002, 17:1728-1730.
44. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
45. Aicher A., Heeschen C., Mildner-Rihm C., C.Urbich C., C.Ihling C., Technau-Ihling K., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003, 9:1371-1376.
46. Bellien J., Thuillez C., Joannides R. Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans. Fundam Clin Pharmacol 2008, 22:363-377.
47. Tare M., Emmett S.J., Coleman H.A., Skordilis C., DW.Eyles D.W., Morley R., et al. Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol 2011, 589:4777-4786.
48. Wong M.S., Delansorne R., Man R.Y., Svenningsen P., Vanhoutte P.M. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2010, 299:1226-1234.
49. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
50. 3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int 2008, 74:170-179.
51. Krishnaveni G.V., Veena S.R., Winder N.R., JC.Hill J.C., Noonan K., Boucher B.J., et al. Maternal vitamin D status during pregnancy and body composition and cardiovascular risk markers in Indian children. The Mysore Parthenon Study. Am J Clin Nutr 2011, 93:628-635.
52. Crozier S.R., Harvey N.C., Inskip H.M., Godfrey K.M., Cooper C., Robinson S.M., et al. Maternal vitamin D status is associated with adiposity in the offspring: findings from the Southampton Women's Survey. Am J Clin Nutr 2012, 96:57-63.
53. Gale C.R., Robinson S.M., Harvey N.C., Javaid M.K., Jiang B., Martyn C.N., et al. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr 2008, 62:68-77.
54. Williams D.M., Fraser A., Fraser W.D., Hypponen E., Smith G.V., Deanfield J., et al. Associations of maternal 25-hydroxyvitamin D in pregnancy with offspring cardiovascular risk factors in childhood and adolescence: findings from the Avon longitudinal Study of parents and children. Heart 2013, 99:1849-1856.
55. Merke J., Milde P., Lewicka S., Hugel U., Klaus G., Mangelsdorf D.J., et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25 dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989, 83:1903-1915.
56. Zehnder D., Bland R., Chana R.S., Wheeler D.C., Howie A.J., Williams M.C., et al. Synthesis of 1,25-dihydroxyvitamin D3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002, 13:621-629.
57. Hollis B.W., Wagner C.L. The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 2013, 98:4619-4628.
58. Zhong W., Gu B., Gu Y., Groome L.J., Sun J., Wang Y. Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells. J Steroid Biochem Mol Biol 2014, 140:56-62.
59. Cardus A., Parisi E., Gallego G., Aldea M., Fernandez E., Valdivielso J.M. 1,25 Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF mediated pathway. Kidney Int 2006, 69:1377-1384.
60. Rebsamen M.C., Sun J., Norman A.W., Liao J.K. 1alpha, 25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 2002, 91:17-24.
61. Proudfoot D., Skepper J.N., Hegyi L., Bennet M.R., Shanahan C.M., Weissberg P.L. Apoptosis regulates human vascular calcification in vitro-evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000, 87:1055-1062.
62. Aoshima Y., Mizobuchi M., Ogata H., Kumata C., Nakazawa A., Kondo F., et al. Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α. Nephrol Dial Transplant 2012, 27:1800-1806.
63. Molinari C., Uberti F., Grossini E., Vacca G., Carda S., Invernizzi M., et al. 1α, 25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem 2011, 27:661-668.
64. 2 oxidant injury through the Erk/Erk-Sirt-1axis activation. J Cardiovasc Transl Res 2013, 6:221-231.
65. Uberti F., Lattuada D., V.Morsanuto V., U.Nava U., Bolis G., Vacca G., et al. Vitamin D protects Human Endothelial Cells from oxidative stress through autophagic and survival pathways. J Clin Endocrinol Metab 2013, 10.1210/jc.2013-2103.
66. Jablonski K.L., Chonchol M., Pierce G.L., Walker A.E., Seals D.R. 25-hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011, 57:63-69.
67. Equils O., Naiki Y., Shapiro A.M., Michelsen K., Lu D., Adams J., et al. 1,25-dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol 2006, 143:58-64.
68. Martinesi M., Bruni S., Stio M., Treves C. 1,25-Dihydroxyvitain D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells. Cell Biol Int 2006, 30:365-375.
69. Codoner-Franch P., Tavarez-Alonso S., Simo-Jorda R., Laporta-Martin P., Carratala Calvo A., Alonso-Iglesias E. Vitamin D status is linked to biomarkers of oxidative stress, inflammation, and endothelial activation in obese children. J Pediatr 2012, 161:848-854.
70. Stach K., Kälsch A.I., Nguyen X.D., Elmas E., Kralev S., Lang S., et al. 1α,25-dihydroxyvitamin D3 attenuates platelet activation and the expression of VCAM-1 and MT1-MMP in human endothelial cells. Cardiology 2011, 118:107-115.
71. Talmor Y., Golan E., Benchetrit S., Bernheim J., Klein O., Green J., et al. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 2008, 294:F1059-F1064.
72. 2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients. J Steroid Biochem Mol Biol 2013, 136:309-312.
73. Karohl C., Vaccarino V., Veledar E., Goldberg J., Tangpricha V., Bellasi A., Raggi P. Vitamin D status and coronary flow reserve measured by positron emission tomography: a co-twin control study. J Clin Endocrinol Metab 2013, 98:389-397.
74. Ott C., Raff U., Schneider M.P., Totze S.I., Schmieder R.E. 25-Hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment. Clin Res Cardiol 2013, 102:299-304.
75. Oz F., Cizqici A.Y., Oflaz H., Elitok A., Karaayvaz E.B., Mercanoglu F., et al. Impact of vitamin D insufficiency on the epicardial coronary flow velocity and endothelial function. Coron Artery Dis 2013, 24:392-397.
76. Munisamy S., Kamaliah M.D., Suhaidarwani A.H., Zahiruddin W.M., Rasool A.H. Impaired microvascular endothelial function in vitamin D deficient diabetic nephropathy patients. J Cardiovasc Med 2013, 14:466-471.
77. Syal S.K., Kapoor A., Bhatia E., Sinha A., Kumar A.S., Tewari S., et al. Vitamin D deficiency, coronary artery disease, and endothelial dysfunction: observations from a coronary angiographic study in Indian patients. J Invasive Cardiol 2012, 24:385-389.
78. Ertek S., Akgul E., Cicero A.F., Kutuk U., Demirtas S., Cehreli S., Erdogan G. 25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women. Arch Med Sci 2012, 8:47-52.
79. Alvarez J.A., Gower B.A., Calhourn D.A., Judd S.E., Dong Y., Dudenbostel T., et al. Serum 25-hydroxyvitamin D and ethnic differences in arterial stiffness and endothelial function. J Clin Med Res 2012, 4:197-205.
80. Al Mheid I., Patel R., Murrow J., Morris A., A.Rahman A., Fike L., et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol 2011, 58:186-192.
81. Yiu Y.F., Chan Y.H., Yiu K.H., Siu C.W., Li S.W., Wong L.Y., et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 2011, 96:E830-E835.
82. Mikirova N.A., Belcaro G., Jackson J.A., Riordan N.H. Vitamin D concentrations, endothelial progenitor cells and cardiovascular risk factors. Panminerva Med 2010, 52:81-87.
83. Ngo D.T., Sverdlov A.L., McNeil J.J., Horowitz D. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations?. Am J Med 2010, 123:335-341.
84. Liu E., Meigs J.B., Pittas A.G., Economos C.D., McKeown N.M., Booth S.L., Jacques P.F. Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring study. Am J Clin Nutr 2010, 91:1627-1633.
85. Van Schooten F.J., Hirvonen A., Maas L.M., De Mol B.A., Kleinjans J.C., Bell D.A., Durrer J.D. Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J 1998, 12:1409-1417.
86. Witham M.D., Ireland S., Houston J.G., Gandy S.J., Waugh S., Macdonald T.M., Mackenzie I.S., Struthers A.D. Vitamin D therapy to reduce blood pressure and left ventricular hypertrophy in resistant hypertension: randomised controlled trial. Hypertension 2014, 10.1161/HYPERTENSIONAHA.113.02177.
87. Witham M.D., Adams F., Kabir G., Kennedy G., Belch J.J., Khan F. Effect of short term vitamin D supplementation on markers of vascular health in South Asian women living in the UK - A randomised controlled trial. Atherosclerosis 2013, 230:293-299.
88. Yiu Y.F., Yiu K.H., Siu C.W., Chan Y.H., Li S.W., Wong L.Y., et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013, 227:140-146.
89. Witham M.D., Price R.J., Struthers A.D., Donnan P.T., Messow C.M., Ford I., et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomised controlled trial. JAMA Intern Med 2013, 173(18):1672-1679.
90. Witham M.D., Dove F.S., Khan F., Lang C.C., Belch J.J., Struthers A.D. Effects of vitamin D supplementation on markers of vascular function after myocardial infarction-a randomized controlled trial. Int J Cardiol 2013, 167:745-749.
91. Witham M.D., Dove F.J., Sugden J.A., Doney A.S., Struthers A.D. The effect of vitamin D supplement on markers of vascular health in stroke patients - A randomized controlled trial. Nutr Metab Cardiovasc Dis 2012, 22:864-870.
92. Gepner A.D., Ramamurthy R., Krueger D.C., Korcarz C.E., Binkley N., Stein J.H. A prospective randomised controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One 2012, 7(2):36617.
93. Stricker H., Tosi Bianda F., S.Guidicelli-Nicolosi S., Limoni C., Colucci G., et al. Effect of a single, oral, high-dose vitamin D supplemetation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg 2012, 44:307-312.
94. Longenecker C.T., Hileman C.O., Carman T.L., Ross A.C., Seydafkan S., Brown T.T., et al. Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther 2012, 17:613-621.
95. Sokol S.I., Srinivas V., Crandall J.P., Kim M., Tellides G., Lebastchi A.H. The effects of vitamin D repletion on endothelium function and inflammation in patients with coronary artery disease. Vasc Med 2012, 17:394-404.
96. Harris R.A., Pederson-White J., Guo D.H., Stallmann-Jorgensen I.S., Keeton D., Huang Y., et al. Vitamin D3 supplementation for 16weeks improves flow mediated dilation in overweight African-American adults. Am J Hypertens 2011, 24:557-562.
97. Witham M.D., Dove F.J., Dryburgh M., Sugden J.A., Morris A.D., Struthers A.D. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010, 53:2112-2119.
98. Tarcin O., Yavuz D.G., Ozben B., Telli A., Ogunc A.V., Yuksel M., et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009, 94:4023-4030.
99. Sugden J.A., Davies J.I., Witham M.D., Morris A.D., Struthers A.D. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008 Mar, 25:320-325.
100. Cipriani C., Romagnoli E., Scillitani A., Chiodini I., Clerico R., Carnevale V., et al. Effect of a single oral dose of 600,000IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 2010, 95:4771-4777.
101. Petrofsky J., Alshammari F., Khowailed I.A., Rodrigues S., Potnis P., Akerkar S., et al. The effect of acute administration of vitamin D on micro vascular endothelial function in Caucasians and South Asian Indians. Med Sci Monit 2013, 19:641-647.
102. Hossein-nezhad A., Spira A., Holick M.F. Influence of vitamin D status and vitamin D3 supplementation on genome wide epression of white blood cells: a randomized double-blind clinical trial. PLoS One 2013, 8:e58725. 10.1371/journal.pone.0058725.
103. Shepherd L., Souberville J.C., Bastard J.P., S.Fellahi S., J.Capeau J., J.Reekie J., et al. Prognostic value of vitamin D level for all-cause mortality and association with inflammatory markers, in HIV-infected persons. J Infect Dis 2014, 10.1093/infdis/jiu074.
104. Rohrmann S., Braun J., Bopp M., Faeh D., Swiss National Cohort (SNC) Inverse association between circulating vitamin D and mortality-dependent on sex and cause of death?. Nutr Metab Cardiovasc Dis 2013, 23:960-966.
105. Sempos C.T., Durazo-Arvizu R.A., Dawson-Hughes B., Yetley E.A., Looker A.C., Schleicher R.L., et al. Is there a reverse J shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. J Clin Endocrinol Metab 2013, 98:3001-3009.
106. Schottker B., Haug U., Schomburg L., Köhrle J., Perna L., Müller H., et al. Strong associations of 25-hydroxyvitamin D concentrations with all cause, cardiovascular, cancer and respiratory disease mortality in a large cohort study. Am J Clin Nutr 2013, 97:782-793.
107. Schottker B., Ball D., Gellert C., Brenner H. Serum 25-hydroxyvitamin D levels and overall mortality: a systematic review and meta-analyses of prospective cohort studies. Ageing Res Rev 2013, 12:708-718.
108. Tomson J., Emberson J., Hill M., Gordon A., Armitage J., M.Shipley M., et al. Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deaths. Eur Heart J 2013, 34:1365-1374.
109. Lin S.W., Chen W., Fan D.H., Dawsey S.M., Taylor P.R., Qiao Y.L., et al. Prospective study of serum 25-hydroxyvitamin D concentration and mortality in a Chinese population. Am J Epidemiol 2012, 176:1043-1050.
110. De Boer I.H., Levin G., Robinson-Cohen C., Biggs M.L., Hoofnagle A.N., Siscovick D.S., et al. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med 2012, 156:627-634.
111. Wang L., Song Y., Manson J.E., Pilz S., März W., Michaëlsson K. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012, 5:819-829.
112. Dror Y., Giveon S.M., Hoshen M., Feldhamer I., Balicer R.D., Feldman B.S. Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J Clin Endocrinol Metab 2013, 98:2160.
113. Eisman J.A. When is a U-curve actually a J-curve? Is it really too much of a good thing?. J Clin Endocrinol Metab 2013, 98:1863-1864.
114. Liu L., Chen M., Hankins S.R., DREXEL Cardiovascular Health Collaborative Education, Research, and Evaluation Group, et al. Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease and premature mortality from all-cause in United States adults. Am J Cardiol 2012, 110:834-839.
115. Grandi N.C., Breitling L.P., Brenner H. Vitamin D and cardiovascular disease: systematic review and metanalyses of prospective studies. Prev Med 2010, 51:228-233.
116. Zittermann A., Kuhn J., Dreier J., Knabbe C., Gummert J.F., Borgermann J. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur Heart J 2013, 34:1358-1364.
117. Lomashvili K., Wang X., O'Neill W.C. Role of local versus systemic vitamin D receptors in vascular calcification. Arterioscler Thromb Vasc Biol 2014, 34:146-151.
118. Sun Q., Pan A., Hu F.B., Manson J.E., Rexrode K.M. 25-Hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke 2012, 43:1470-1477.
119. Tu W.J., Zhao S.J., Xu D.J., Chen H. Serum 25-hydroxyvitamin D predicts the short term outcomes of Chinese patients with acute ischemic stroke. Clin Sci (Lond) 2014, 126:339-346.
120. Amrein K., Quraishi S.A., Litonjua A.A., et al. Evidence for a U-shaped relationship between pre-hospital vitamin D status and mortality: a cohort study. J Clin Endocrinol Metab Jan 13 2014, jc20133481. 10.1210/jc.2013-3481.
121. Hsia J., Heiss G., Ren H., et al. Calcium/Vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846-854.
122. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469-475.
123. Inkovaara J., Gothoni G., Halttula R., Heikinheimo R., Tokola O. Calcium, vitamin D and anabolic steroid in treatment of aged bones: double-blind placebo-controlled long-term clinical trial. Age Ageing 1983, 12:124-130.
124. Avenell A., MacLennan G.S., Jenkinson D.J., et al. Long term followup for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab 2012, 97:614-622.
125. Elamin M.B., Abu Elnour N.O., Elamin K.B., et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:1931-1942.
126. Bjelakovic G., Gluud L.L., Nikolova D., et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2014, 1:CD007470.
127. Zheng Y., Zhu J., Cui L., Yao W., Liu Y. Meta-analyses of long term vitamin D supplementation on overall mortality. PLoS One 2013, 8:e82109.
128. Bolland M.J., Grey A., Gamble G.D., Reid I.R. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analyses. Lancet Diabetes Endocrinol 2014, 10.1016/S2213-8587(13)70212-2.
129. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analyses of randomized controlled trials. Arch Intern Med 2007, 167:1730-1737.
130. Feelisch M., Kolb-Bachofen B., Liu D., et al. Is sunlight good for our heart?. Eur Heart J 2010, 31:1041-1045.
131. Paunel A.N., Dejam A., Thelen S., et al. Enzyme-independent nitric oxide formation during UVA challenge of human skin: characterization, molecular sources, and mechanisms. Free Radic Biol Med 2005, 38:606-615.
132. Oplander C., Volkmar C.M., Paunel-Gorgulu A., et al. Whole body UVA irradiation lowers systemic blood pressure by release of nitric oxide from intracutaneous photolabile nitric oxide derivatives. Circ Res 2009, 105:1031-1040.